CSL 1H Profit Misses Estimates on Weak Vaccine Sales

Jeffrey L. Klump February 10, 2025 1 minute read

CSL 1H Profit Misses Estimates on Weak Vaccine Sales

CSL CEO Paul McKenzie has reiterated the company’s revenue growth guidance, even after first-half net income of the world’s second-largest manufacturer of influenza vaccines came below analysts’ expectations. He speaks exclusively with Haidi Stroud-Watts on “Bloomberg: The China Show.” (Source: Bloomberg)

About The Author

Jeffrey L. Klump

I am 62 years old and widowed with 2 children. I live in Creve Coeur, MO. USA which is a suburb of Saint Louis. I am a Digital Marketer, Blogger, Writer, SEO Expert, and Work from Home Business Opportunity Specialist. I am the owner & administrator of the MEK Enterprises Blog. Please contact me if you have any questions. Thank you.

See author's posts

Related

Discover more from MEK Enterprises Blog - Breaking News, SEO, Information, and Making Money Online!

Subscribe to get the latest posts sent to your email.

Leave a ReplyCancel reply